You just read:

Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin

News provided by

Medimetriks Pharmaceuticals, Inc.

Jul 30, 2015, 09:30 ET